GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients

Human Reproduction

Volumn 28, Issue 9, 2013, Pages 2593-2594

  Humaidan, Peter ^a   Thomsen, Lise H ^a   Alsbjerg, Birgit ^a  

^a SKIVE REGIONAL HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST;

BOLUS INJECTION; EMBRYO TRANSFER; FEMALE; HIGH RISK PATIENT; HUMAN; LETTER; LUTEAL PHASE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SINGLE DRUG DOSE;

CHORIONIC GONADOTROPIN; CORPUS LUTEUM; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION;

EID: 84883197086     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det287     Document Type: Letter

References (7)

1. Bodri D. Low-dose hCG supplementation after GnRH agonist triggering: don't be too quick on the trigger. Hum Reprod 2013;28:2315-2317.
2. Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod Biomed Online 2009; 18:630-634.
3. Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grondahl ML, Westergaard L, Andersen CY. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005;20:1213-1220. (Pubitemid 40796107)
4. Humaidan P, Ejdrup BH, Westergaard LG, Yding AC. 1, 500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for f Human Reproduction and Embryology. All rights reserved. 2594 ovulation induction: a prospective, randomized, controlled study. Fertil '■ Steril 2010;93:847-854.
5. Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY. (2013) GnRH agonist trigger and individualized luteal phase hCG support according to ovarian response to stimulation-two multi-centre RCTs in IVF patients. Hum Reprod 2013;28:251 1-2521.
6. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van SA, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 2006; 85:1 12-120. (Pubitemid 43063432)
7. Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU h CG. Hum Reprod 2013;28:2522-2528.